PHI with Tick-borne encephalitis (TBE)
How does this condition affect your private health insurance?
Tick-borne encephalitis (TBE) is a viral infection of the central nervous system transmitted by ticks. The "Zeckenimpfung" (tick vaccination) is its primary prevention. TBE often presents in two phases: an initial flu-like illness, followed by potential neurological symptoms like meningitis or encephalitis. These can range from headaches and fever to severe complications such as paralysis, seizures, and cognitive dysfunction. While many recover completely, a significant proportion experience persistent neurological sequelae, impacting quality of life. There's no specific cure; treatment is supportive. Vaccination offers vital protection against this potentially debilitating disease.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 10%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically 1-4 weeks for the acute phase, but neurological symptoms can persist longer.
Duration of Illness (Lifetime)
Can be a one-time event with full recovery, or a chronic condition if severe neurological sequelae develop.
Cost of Treatment (Initial)
Highly variable, from hundreds to tens of thousands of Euros/Dollars, depending on severity, hospitalization, and initial rehabilitation.
Cost of Treatment (Lifetime)
Can range from minimal if complete recovery occurs, to hundreds of thousands or even millions for long-term care, rehabilitation, and support for severe neurological disabilities.
Mortality Rate
Approximately 1-2% for European TBE strains, but higher (up to 20%) for Far Eastern subtypes.
Risk of Secondary Damages
Moderate to high (20-50%), including persistent headaches, fatigue, concentration difficulties, cognitive impairments, paresis, and psychiatric issues.
Probability of Full Recovery
Moderate (50-80%), with a significant proportion experiencing long-term neurological or psychological sequelae.
Underlying Disease Risk
TBE is a viral infection; it does not typically cause other underlying diseases, nor is it strongly associated with them at onset, beyond general health status influencing severity. Its primary impact is direct neurological damage.